BIOS Fund I, LP - 27 Jun 2025 SCHEDULE 13D/A Report for Actuate Therapeutics, Inc. Common Stock, par value $0.000001 per share (ACTU)

Filing manager
BIOS Fund I, LP
Reporting owner
AARON G.L. FLETCHER
Security
Actuate Therapeutics, Inc. Common Stock, par value $0.000001 per share
Beneficially owned shares
10,267,232 shares
Ownership signal CIK-linked ownership evidence from parsed SEC filings. 2 signals
Large-stake signal

Form

SCHEDULE 13D/A

Active or control-oriented beneficial ownership filing.

Ownership

50%

Beneficial ownership of this reported class.

Shares

10,267,232 shares

Shares beneficially owned as disclosed.

Event date

27 Jun 2025

Date tied to the ownership event or amendment.

Accepted by SEC

30 Jun 2025

EDGAR acceptance date.

How to read this large-stake filing
  • Schedule 13D/G filings focus on beneficial ownership stakes, not a full portfolio.
  • Compare this filing with the holder history and issuer page before treating the percentage as a current position.
  • Use amendments to understand whether the disclosed stake increased, decreased, or changed reporting status.
Class ownership
50%
Subject security Names, identifiers, and filing context for this profile. 2 source fields
Symbol
ACTU
Shares outstanding
20,616,932 shares
Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
SCHEDULE 13D/A
Accepted by SEC
30 Jun 2025, 12:08:12 UTC
Event date
27 Jun 2025
Prior SEC filing
27 May 2025
Source filing
View source filing

Key filing fact

BIOS Fund I, LP disclosed 50% ownership in Actuate Therapeutics, Inc. Common Stock, par value $0.000001 per share (ACTU) on 27 Jun 2025.

Key facts

  • BIOS Fund I, LP filed SCHEDULE 13D/A for Actuate Therapeutics, Inc. Common Stock, par value $0.000001 per share (ACTU).
  • Disclosed ownership: 50%.
  • Date of event: 27 Jun 2025.

Change

  • Previous schedule filing date: 27 May 2025.
  • Current filing was accepted on 30 Jun 2025, 12:08.

Research use

  • This page turns one Schedule 13D/G filing into a quick large-stake read before the raw reporting-person rows.
  • Use the linked SEC filing as the source of truth for ownership percentages, shares, and reporting-party details.

Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

View source filing

Reporting persons

Disclosed reporting parties (24)

Names, ownership percentages, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name Ownership Shares owned Sole voting power Shared voting power Signature Title CIK
BIOS FUND I, LP 2.6% 525,797 0 525,797 John Fucci Attorney-in-Fact 0001697316
BIOS FUND I QP, LP 1.5% 307,538 0 307,538 John Fucci Attorney-in-Fact 0001700297
BIOS FUND II, LP 1.5% 308,211 0 308,211 John Fucci Attorney-in-Fact 0001714576
BIOS FUND II QP, LP 4.9% 1,006,788 0 1,006,788 John Fucci Attorney-in-Fact 0001716869
BIOS FUND II NT, LP 0.7% 134,776 0 134,776 John Fucci Attorney-in-Fact 0001728851
BIOS FUND III, LP 1.9% 383,791 0 383,791 John Fucci Attorney-in-Fact 0001791917
BIOS FUND III QP, LP 12% 2,506,667 0 2,506,667 John Fucci Attorney-in-Fact 0001791916
BIOS FUND III NT, LP 2% 404,814 0 404,814 John Fucci Attorney-in-Fact 0001791910
BP DIRECTORS, LP 0.6% 116,801 0 116,801 John Fucci Attorney-in-Fact 0001813311
BIOS ACTUATE CO-INVEST I, LP 1.5% 300,749 0 300,749 John Fucci Attorney-in-Fact 0001771378
BIOS ACTUATE CO-INVEST II, LP 10% 2,094,650 0 2,094,650 John Fucci Attorney-in-Fact 0001825398
BIOS ACTUATE CO-INVEST III, LP 2.8% 573,394 0 573,394 John Fucci Attorney-in-Fact 0001956704
BIOS CLINICAL OPPORTUNITY FUND, LP 6.2% 1,259,427 0 1,259,427 John Fucci Attorney-in-Fact 0001988639
BIOS 2024 CO-INVEST, LP 1.3% 267,856 0 267,856 John Fucci Attorney-in-Fact 0002028708
BIOS EQUITY PARTNERS, LP 4.6% 950,136 0 950,136 John Fucci Attorney-in-Fact 0001813314
BIOS EQUITY PARTNERS II, LP 8.5% 1,750,524 0 1,750,524 John Fucci Attorney-in-Fact 0001813313
BIOS EQUITY PARTNERS III, LP 29% 5,963,316 0 5,963,316 John Fucci Attorney-in-Fact 0001831976
BIOS EQUITY COF, LP 7.4% 1,527,283 0 1,527,283 John Fucci Attorney-in-Fact 0002000747
CAVU MANAGEMENT, LP 42% 8,663,976 0 8,663,976 John Fucci Attorney-in-Fact 0001813270
BIOS CAPITAL MANAGEMENT, LP 50% 10,191,259 0 10,191,259 John Fucci Attorney-in-Fact 0001813845
CAVU ADVISORS, LLC 42% 8,663,976 0 8,663,976 John Fucci Attorney-in-Fact 0001813310
BIOS ADVISORS GP, LLC 50% 10,191,259 0 10,191,259 John Fucci Attorney-in-Fact 0001813844
LESLIE W. KREIS 43% 8,733,351 69,375 8,663,976 John Fucci Attorney-in-Fact 0001813316
AARON G.L. FLETCHER 50% 10,267,232 60,973 10,048,403 John Fucci Attorney-in-Fact 0001789490
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .